cilastatin has been researched along with Acute Kidney Failure in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 4 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gómez-Gómez, MM; Lázaro, A; Marazuela, MD; Moreno-Gordaliza, E; Pastor, Ó | 1 |
Cui, L; Han, J; Hu, F; Wang, R; Yu, F; Yuan, H | 1 |
Andeen, NK; Eiwaz, MB; Groat, T; Hebert, JF; Hutchens, MP; Munhall, AC; Nickerson, MN; Pai, AA | 1 |
Eiwaz, MB; Funahashi, Y; Hebert, JF; Hutchens, MP; Matsushita, K; McCormick, JA; Mori, K; Munhall, AC; Nickerson, MN; Saritas, T; Yanagita, M | 1 |
Bonventre, JV; Camaño, S; González-Nicolás, MÁ; Humanes, B; Lara, JM; Lázaro, A; Sabbisetti, V; Tejedor, A | 1 |
Gil, HW; Hwang, HS; Im, DS; Jung, SY; Shin, HJ; Song, HY; Yang, KJ | 1 |
Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
Gil, HW; Hwang, HS; Im, DS; Jin, J; Jin, L; Lim, SW; Luo, K; Yang, CW | 1 |
Brett, S; Cotton, A; Franklin, BD; Holmes, A | 1 |
Caramelo, C; Castilla, M; de Lucas, C; Lazaro, JA; Tejedor, A; Torres, AM | 1 |
Macias, WL; Mueller, BA; Scarim, SK | 1 |
Dehne, MG; Kroh, UF | 1 |
Bernis, C; Fernández-Rañada, JM; Gruss, E; Rodriguez, F; Tomás, JF; Traver, JA | 1 |
Bremer, F; Brune, K; Geisslinger, G; Oelkers, R; Schobel, H; Schüttler, J; Tegeder, I | 1 |
Vincent, HH; Vos, MC; Yzerman, EP | 1 |
Bengel, D; Przechera, M; Risler, T | 1 |
Horowitz, E; Lee, HC; Linder, W | 1 |
Böhler, J; Fecht, H; Keller, E; Schollmeyer, P | 1 |
Keller, E | 1 |
Schliamser, SE | 1 |
3 review(s) available for cilastatin and Acute Kidney Failure
Article | Year |
---|---|
Using imipenem and cilastatin during continuous renal replacement therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cilastatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors | 2005 |
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.
Topics: Acute Kidney Injury; Cilastatin; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipenem; Kidney Function Tests; Male; Probability; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2007 |
Drug therapy during continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Cilastatin; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate | 1989 |
2 trial(s) available for cilastatin and Acute Kidney Failure
Article | Year |
---|---|
Imipenem/cilastin dosage during acute renal failure and hemofiltration.
Topics: Acute Kidney Injury; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Hemofiltration; Humans; Imipenem | 1995 |
Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis.
Topics: Acute Kidney Injury; Adult; Bone Marrow Transplantation; Cilastatin; Cyclosporine; Female; Graft vs Host Disease; Humans; Imipenem; Immunosuppressive Agents; Kidney; Leukemia; Male; Protease Inhibitors; Retrospective Studies; Transplantation, Homologous | 1996 |
15 other study(ies) available for cilastatin and Acute Kidney Failure
Article | Year |
---|---|
Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by Cilastatin.
Topics: Acute Kidney Injury; Animals; Apoptosis; Chromatography, Liquid; Cilastatin; Cisplatin; Glomerular Filtration Rate; Humans; Kidney; Lipid Metabolism; Lipidomics; Lipids; Rats; Tandem Mass Spectrometry | 2021 |
Megalin blockade with cilastatin ameliorates multiple wasp sting-induced acute kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Biomarkers; Cilastatin; Creatine Kinase; Insect Bites and Stings; Kidney; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Myoglobin; Rats; Rats, Wistar; Rhabdomyolysis; Wasp Venoms; Wasps | 2022 |
Legal Performance-enhancing Drugs Alter Course and Treatment of Rhabdomyolysis-induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Caffeine; Cilastatin; Glycerol; Humans; Ibuprofen; Mice; Performance-Enhancing Substances; Rhabdomyolysis | 2023 |
Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice.
Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Urea Nitrogen; Cilastatin; Disease Models, Animal; Endocytosis; Glomerular Filtration Rate; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Knockout; Myoglobin; Myoglobinuria; Protease Inhibitors; Rhabdomyolysis | 2021 |
Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Blood Urea Nitrogen; Cilastatin; Cisplatin; Creatinine; Cytokines; Drug Evaluation, Preclinical; Glomerular Filtration Rate; Kidney Tubules, Proximal; Male; Nephritis; NF-kappa B; Protease Inhibitors; Rats; Rats, Wistar | 2017 |
Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
Topics: Acute Kidney Injury; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Proliferation; Cilastatin; Cytoprotection; Dose-Response Relationship, Drug; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Time Factors; Vancomycin | 2017 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cilastatin; Humans; Immunosuppressive Agents; Male; Oxidative Stress; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2019 |
Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Hemofiltration; Humans; Imipenem; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 1993 |
Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Area Under Curve; Cilastatin; Cilastatin, Imipenem Drug Combination; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hemofiltration; Humans; Imipenem; Liver; Male; Middle Aged | 1997 |
Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Cilastatin; Drug Combinations; Female; Half-Life; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged; Reference Standards | 1992 |
Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Bacterial Infections; Cilastatin; Cross Infection; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
Treatment of tularemia with imipenem/cilastatin sodium.
Topics: Acute Kidney Injury; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Middle Aged; Tularemia | 1991 |
Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
Topics: Acute Kidney Injury; Adult; Aged; Bacterial Infections; Cilastatin; Critical Care; Drug Therapy, Combination; Female; Hemofiltration; Humans; Imipenem; Male; Middle Aged | 1989 |
Neurotoxicity of beta-lactam antibiotics. Experimental kinetic and neurophysiological studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Enterobacteriaceae Infections; Female; Hippocampus; Imipenem; Male; Meningitis; Penicillin G; Rabbits; Rats; Rats, Inbred Strains; Seizures; Thiopental; Tissue Distribution; Uremia | 1988 |